Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions
.jpg?width=1200&auto=webp&trim=118,0,119,0#)
Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of the drugs that have not been approved by the FDA
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
